Status and phase
Conditions
Treatments
About
Phase I Study of the Safety and Preliminary Efficacy of Human induced pluripotent stem cells-derived Retinal Pigment Epithelial Cells (hiPSC-RPEs) Subretinal Transplantation in Adanced (Late-Stage) Age-Related Macular Degeneration(AMD) Patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Ocular Treatments:
Systemic Diseases, Treatments, and Other Conditions:
Primary purpose
Allocation
Interventional model
Masking
12 participants in 1 patient group
Loading...
Central trial contact
Songtao Yuan, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal